胆固醇 、
(9Z,11E)-13-Oxo-trideca-9,11-dienoic acid 在
4-二甲氨基吡啶 、
N,N'-二环己基碳二亚胺 作用下,
以
氯仿 为溶剂,
反应 20.0h,
生成 (9Z,11E)-13-Oxo-trideca-9,11-dienoic acid (3S,8S,9S,10R,13R,14S,17R)-17-((R)-1,5-dimethyl-hexyl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl ester 、 (9E,11E)-13-Oxo-trideca-9,11-dienoic acid (3S,8S,9S,10R,13R,14S,17R)-17-((R)-1,5-dimethyl-hexyl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl ester